SOURCE: National Disability Institute

National Disability Institute

September 03, 2014 09:00 ET

National Disability Institute Presents Fourth Annual Financial Wellness Webinar Series for People Living With Multiple Sclerosis

Program Provides Free Information and Expert Insight to Address Unique Financial Challenges Faced by People Living With MS

WASHINGTON, DC--(Marketwired - September 03, 2014) - On September 17, 2014, National Disability Institute will launch the fourth annual Financial Wellness Webinar Series designed to help people living with multiple sclerosis (MS) plan for their financial futures. Expert guests with backgrounds in law, finance and public benefits will share their insight on topics including taxes, employment, social security and credit. All resources and information presented in the series will be tailored to address the unique challenges faced by people living with MS who require careful planning and preparation in order to maintain financial stability. More than 1,500 people registered for the webinars in 2013, which are made available free of charge with support from Acorda Therapeutics.

In 2011, National Disability Institute conducted an online survey of 3,000 people living with MS, with 67 percent of respondents reporting that their financial positions declined after their MS diagnosis. In addition, 74 percent reported that they did not use financial planning programs or strategies to manage or stabilize their finances. Survey findings led National Disability Institute to partner with Acorda Therapeutics to launch the Financial Wellness Webinar Series. A new report released by National Disability Institute in July 2014 on the financial capability of people with disabilities underscored those findings, with 78 percent of people with disabilities reporting they had difficulty making ends meet, as compared with 56 percent of people without disabilities.

"Learning financial fundamentals is one of the first and most important steps in building life-long financial wellness," said Michael Morris, executive director of National Disability Institute. "This free webinar series offers people living with MS a unique opportunity to learn more about their money and available options to help them make more informed choices about their financial futures. We are grateful Acorda Therapeutics has joined National Disability Institute to make this important program available to people living with MS and their families."

The first webinar in the series will be held Wednesday, September 17, 2014 at 3:00 p.m. ET and will last 90 minutes. Hosted by nationally renowned financial literacy advisor Marlene Ware, participants will learn basic steps that may lead to improved financial independence and security.

Subsequent webinars will be held on the third Wednesday of each month through January 2015, with the exception of December. Each webinar consists of a one-hour expert presentation followed by a half-hour set aside for questions from participants. In addition, guest speakers who live with MS will offer a peer perspective during each webinar. There is no cost to participate in the webinars, but registration is required. Visit for more information and to register for any of the four webinars in the series.

  • Taking a First Step Toward Improved Financial Wellness - presented by financial literacy advisor Marlene Ware, September 17, 2014, 3:00 p.m. - 4:30 p.m. ET
  • Social Security Disability Benefits: Informed Decision Making - presented by National Disability Institute employment expert Kevin Nickerson, October 15, 2014, 3:00 p.m. - 4:30 p.m. ET
  • Credit: Accessing It, Understanding It, Using It Wisely - November 19, 2014, 3:00 p.m. - 4:30 p.m. ET
  • New Year, New Financially Secure You - January 21, 2015, 3:00 p.m. - 4:30 p.m. ET

"Advance planning and preparation is essential for people living with MS because their ability to continue to work and remain financially independent may be compromised," said Tierney Saccavino, Senior Vice President of Corporate Communications at Acorda Therapeutics. "People with MS are often dealing with unique financial challenges, and it is very important for us to support resources like this webinar series which provides tools and information needed to help overcome those challenges."

The Financial Wellness Webinar Series is part of National Disability Institute's Real Economic Impact (REI) Network, a resource for policy insights, information, tools and trainings that promote economic advancement for people with disabilities. For more information, follow @RealEconImpact on Twitter and visit NDI website at

About National Disability Institute

National Disability Institute (NDI) is a national non-profit organization dedicated to building a better economic future for people with disabilities. The first national organization committed exclusively to championing economic empowerment, financial education, asset development and financial stability for all persons with disabilities, National Disability Institute effects change through public education, policy development, training, technical assistance and innovative initiatives. National Disability Institute and its Real Economic Impact (REI) Network have helped nearly 2 million people with disabilities receive more than $1.8 billion in tax refunds and credits. To learn more, visit Engage with National Disability Institute on Facebook: RealEconImpact or follow NDI on Twitter: @RealEconImpact.

About Acorda Therapeutics 

Founded in 1995, Acorda Therapeutics is a biotechnology company focused on developing therapies that improve the lives of people with neurological disorders.

Acorda markets three FDA-approved therapies including: AMPYRA® (dalfampridine) Extended Release Tablets, 10 mg, a treatment to improve walking in patients with multiple sclerosis (MS), as demonstrated by an increase in walking speed; ZANAFLEX CAPSULES® (tizanidine hydrochloride) and Zanaflex tablets, a short-acting drug for the management of spasticity; and QUTENZA® (capsaicin) 8% Patch, for the management of neuropathic pain associated with postherpetic neuralgia. AMPYRA is marketed outside the United States as FAMPYRA® (prolonged-release fampridine tablets) by Biogen Idec under a licensing agreement from Acorda.

Acorda has one of the leading pipelines in the industry of novel neurological therapies. The Company is currently developing six clinical-stage therapies and one preclinical stage therapy. This pipeline addresses a range of disorders including post-stroke deficits, epilepsy, cerebral palsy, stroke, peripheral nerve damage, spinal cord injury, neuropathic pain, and heart failure. For more information, please visit the Company's website at:

The following files are available for download:

Contact Information